10 hours ago
Paracetamol pills urgently recalled over contamination fears
Paracetamol pills urgently recalled over contamination fears
A statement issued by the Medicines and Healthcare products Regulatory Agency (MHRA) said Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots)
An urgent recall has been issued for batches of paracetamol which could be contaminated
(Image: Anton Petrus via Getty Images )
Patients have been urged to return certain batches of paracetamol due to contamination fears, according to an announcement made on Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) said that Chelonia Healthcare Limited, the manufacturer, is recalling specific batches of paracetamol 500mg tablets (100 pots) as a precautionary measure, reports the Mirror.
The urgent recall is reportedly "due to contamination following a small number of complaints of discoloured tablets within the pots" and an alert has been issued to anyone who has bought them.
It advises: "Patients or carers should check to see if they have received tablets from the listed batches of Paracetamol 500 mg Tablets. The batch number can be found on the label of the medicine bottle and on the outer carton.
"These tablets can only be obtained from a pharmacy with a prescription. The number of tablets you will have been given will vary depending on your prescription and you may have only received a small number of tablets." For the latest restaurant news and reviews, sign up to our food and drink newsletter here .
Medicine Details:
Paracetamol 500mg Tablets.
Article continues below
PL: 33414/0126.
Active ingredient: Paracetamol.
SNOMED code: 33554711000001108.
GTIN: 05060014445506.
The statement further added: "The tablets should be 'white capsule-shaped tablets, scored on one side', as per the Patient Information Leaflet (PIL). If you find tablets that are discoloured in any way, in pots from the listed batches, please contact your pharmacist or the healthcare professional who dispensed your prescription.
"Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme."
Article continues below
The MHRA has classified the recall as Class 2, suggesting that while the defect could result in mistreatment or harm, it is not deemed life-threatening or serious.
Pharmacists have been given explicit instructions: "Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier, using your supplier's approved process."
